News
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.
Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...
U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...
Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...
The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...
Jackie Collins has opened up about the slightly NSFW side effect she's experienced since using Mounjaro for weight loss ...
Eli Lilly said on Tuesday its drug, Jaypirca, was more effective in a head-to-head study against AbbVie's Imbruvica when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results